04:37 PM EST, 01/07/2025 (MT Newswires) -- Mikhail Eydelman, Senior Vice President, General Counsel, & Corporate Secretary, on January 06, 2025, sold 5,000 shares in Vaxcyte ( PCVX ) for $427,923. Following the Form 4 filing with the SEC, Eydelman has control over a total of 28,222 shares of the company, with 28,222 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649094/000164909425000004/xslF345X05/wk-form4_1736285608.xml